Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemia.

about

Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemia.

Item

http://www.wikidata.org/entity/Q52883093

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Dose-reduced combination of mi ...... and refractory acute leukemia.

@en

Dose-reduced combination of mi ...... and refractory acute leukemia.

@nl

type

Item

label

Dose-reduced combination of mi ...... and refractory acute leukemia.

@en

Dose-reduced combination of mi ...... and refractory acute leukemia.

@nl

prefLabel

Dose-reduced combination of mi ...... and refractory acute leukemia.

@en

Dose-reduced combination of mi ...... and refractory acute leukemia.

@nl

P1476

Dose-reduced combination of mi ...... and refractory acute leukemia

@en

P2093

Chihiro Yamamoto

http://www.w3.org/2001/XMLSchema#string

Daisuke Minakata

http://www.w3.org/2001/XMLSchema#string

Hirofumi Nakano

http://www.w3.org/2001/XMLSchema#string

Iekuni Oh

http://www.w3.org/2001/XMLSchema#string

Kaoru Hatano

http://www.w3.org/2001/XMLSchema#string

Kazuo Muroi

http://www.w3.org/2001/XMLSchema#string

Kazuya Sato

http://www.w3.org/2001/XMLSchema#string

Ken Ohmine

http://www.w3.org/2001/XMLSchema#string

Kento Umino

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Okazuka

http://www.w3.org/2001/XMLSchema#string

P2860

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995)

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

The treatment of acute myeloid leukemia in first relapse: a comprehensive review of the literature.

The myth of the second remission of acute leukemia in the adult.

The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients.

Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experience.

Management of refractory acute myeloid leukemia: re-induction therapy or straight to transplantation?

The role of decitabine for the treatment of acute myeloid leukemia.

Clinical efficacy of mitoxantrone and Ara-C with or without etoposide salvage chemotherapy in adult patients with relapsed or refractory acute lymphoblastic leukemia: retrospective multicenter study of the Korean Adult ALL Working Party.

P304

2541-2547

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2016.1153087

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kiyomi Mashima

P577

2016-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26917050

http://www.w3.org/2001/XMLSchema#string